Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06162026 · ClinicalTrials.gov registry record · NA

Cognitive Screening Made Easy for PCPs - R33 Phase

A NA study of Cognitive Impairment and Cognitive Decline, sponsored by University of Texas at Austin.

Active
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06162026 is a NA study of Cognitive Impairment and Cognitive Decline that is active but no longer recruiting, run by University of Texas at Austin. The registered enrollment target is 500 participants, below the 661-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06162026, a NA study of Cognitive Impairment and Cognitive Decline, is active but no longer recruiting, sponsored by University of Texas at Austin.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will be easier to screen for cognitive impairment, increasing the number of older adults who are screened and thus identified and treated.

Interventions

  • BEHAVIORAL RACS app

Study Locations (1)

Texas

  • Family Wellness Clinic - Austin

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-02-02
Est. Completion 2027-04-30
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT06162026

The ClinicalTrials.gov registry entry for NCT06162026 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 661-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (24% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which RACS app is the first listed.

NCT06162026 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06162026 about?

NCT06162026 is a clinical study titled "Cognitive Screening Made Easy for PCPs - R33 Phase". This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will b...

What is the current status of trial NCT06162026?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2024-02-02. Estimated completion is 2027-04-30.

What conditions does trial NCT06162026 study?

This clinical trial studies the following conditions: Cognitive Impairment, Cognitive Decline, Dementia, Mild.

What interventions are being tested in trial NCT06162026?

The interventions under investigation include: RACS app (BEHAVIORAL).

Who is sponsoring clinical trial NCT06162026?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06162026 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.